LTFS
GEVA

Ladenburg Thalmann Financial Services’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-34
Closed -$3K – 4897
2015
Q1 		$3K Buy
34
+14
+70% +$1.48K ﹤0.01% 4236
2014
Q4 		$2K Buy
20
+8
+67% +$631 ﹤0.01% 4145
2014
Q3 		$1K Sell
12
-7
-37% -$501 ﹤0.01% 3884
2014
Q2 		$2K Buy
+19
New +$1.62K ﹤0.01% 3715

Ladenburg Thalmann Financial Services's GEVA Position: Q2 2015 in Review

Ladenburg Thalmann Financial Services sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 34 shares — an estimated $3K sold.

Ladenburg Thalmann Financial Services first reported a position in GEVA in Q2 2014 and held it in 4 quarters. The position peaked at $3K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Ladenburg Thalmann Financial Services reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 34 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $3K.
  • Ladenburg Thalmann Financial Services first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2014 and held it in 4 quarters.
  • Ladenburg Thalmann Financial Services's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $3K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2015, filed 14 Aug 2015.